World Journal – Are the New Omicron Drugs Distributed According to Ethnicity?

Share Post:

Share on facebook
Share on linkedin
Share on twitter
Share on pinterest
Share on email
政府衛生部門有信息顯示,當局以「族裔」作為分配新冠藥物與防疫物資的標準,且華人聚居社區不在政府優先分配的名單中;亞美醫師協會總裁暨會長劉季高批評政府疫情政治化、長期忽略亞裔社區,指責這種分配方式缺乏科學依據,呼籲政府增加防疫資源,避免疫情擴散。

由於治療新冠病毒的單株抗體(Monoclonal Antibodies)與口服抗病毒藥品數量有限,市衛生局日前發布聲明,遵守州衛生廳最新指南,將「族裔」(Race and Ethnicity)作為藥品分配準則之一,且優先分配給「非洲裔、原住民以及其他有色人種」。

對此,劉季高表示,分配單株抗體與口服抗病毒藥品應根據患者年齡、是否患有免疫系統或基礎疾病等,不應以族裔作為分配的標準,「沒有任何科學依據也不公平」。

曼哈頓西奈山醫院(Mount Sinai Hospital)醫生津伯格(Joel Zinberg)援引一份實驗指出,引起新冠患者最顯著死亡原因是染疫者的年齡,其中50至74歲較18歲到34歲的死亡風險指數高了近7倍、達6.7,85歲以上的患者死亡風險率達10.6。

津伯格表示,少數族裔較白人平均年齡更年輕,但因他們中患有肥胖、糖尿病與腎病的基礎疾病人數較多,恐因「長期系統性的健康與社會不平等」,導致少數族裔染疫者的病情加重;他指,政府可以將避免「歧視」作為分配原則之一,但不應將患者「族裔」視為導致病情加重的風險因素。

此外,市衛生局的一封外洩的文件顯示,當局在分配新冠檢測中心與居家自測包等防疫資源時,也將「族裔」作為考量之一,而市府優先分配資源的33個社區中,華人聚集的皇后區法拉盛市、貝賽、森林小丘以及雷哥公園等,均不在列。

劉季高對此表示,亞裔長期沒有獲得政府的公平資源,疫情爆發初期,華人社區就沒有足夠的檢測中心,疫苗分配後,華人社區也沒有收到足夠的疫苗,導致法拉盛等地疫情指數一度飆高;他呼籲政府合理分配資源,避免防疫政治化,防止疫情再度惡化,「檢測與接種疫苗是避免疫情擴散重要『武器』」。

對於市府以「族裔」優先分配防疫資源,「紐約郵報」曾發表社論指責白思豪(Bill de Blasio)政府沒有根據全市的人口結構分配資源,以所謂的「族裔優先」實施「種族主義」。

 
 

Original post by 《世界日報》

GEORGE C. K. LIU

MD, PHD​

PRESIDENT & CEO​

Dr. George Liu serves as the President, CEO, and CMO of the Chinese-American IPA Inc., d/b/a Coalition of Asian- American IPA (CAIPA), and as Chairman of the Asian-American Accountable Care Organization (AAACO) boards. As an internist and endocrinologist, Dr. Liu has been continuously providing quality care to his patients and contributing to the well-being of the Asian-American communities he has been serving since 1985. In addition to his private practices, he has been an attending physician at various hospitals, such as New York-Presbyterian Lower Manhattan Hospital, Mount Sinai Beth Israel, and NYU Langone Medical Center.

Dr. Liu has received numerous distinctions and honors, including an award from the American Diabetes Association. Top Doctors: New York Metro Area” list by Castle Connolly every year for the last 15 years, and the “Best Doctor” by New York Magazine. Dr. Liu is also recognized and received multiple citations from New York State Assembly, New York City Council, and Commendation from City of New York Office of the Controller. Over the years, he has had various research articles published in collaboration with other distinguished physicians.